CC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Actionable mutations in pancreatic cancer : where targeted therapies are making a difference | BMJ open gastroenterology |  | 2025 | 4 | 84 | ||
| Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review | Clinical colorectal cancer | | 2025 | 16 | 271 | ||
| Narrative Review : Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer Patients | Cancers | | 2025 | 35 | 143 | ||
| Prise en charge du cancer du rectum localisé en 2024 | Revue médicale suisse |  | 2024 | 141 | 0 | ||
| Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy | Cells | | 2023 | 119 | 213 | ||
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | | 2022 | 259 | 245 | ||
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | | 2022 | 187 | 167 | ||
| Emerging Trends for Radio-Immunotherapy in Rectal Cancer | Cancers | | 2021 | 58 | 174 | ||
| Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer | Cancers | | 2021 | 105 | 1,330 |
